Sysmex ADR Change in Accounts Receivable 2016-2024 | SSMXY

Sysmex ADR change in accounts receivable for the twelve months ending December 31, 2024 was $0.320B, a 34.47% increase year-over-year.

  • Sysmex ADR annual change in accounts receivable for 2024 was $-0.146B, a 560.3% increase from 2023.
  • Sysmex ADR annual change in accounts receivable for 2023 was $-0.022B, a 75.94% decline from 2022.
  • Sysmex ADR annual change in accounts receivable for 2022 was $-0.092B, a 12.2% increase from 2021.

Sysmex ADR Change in Accounts Receivable 2016-2024 | SSMXY

  • Sysmex ADR annual change in accounts receivable for 2024 was $-0.146B, a 560.3% increase from 2023.
  • Sysmex ADR annual change in accounts receivable for 2023 was $-0.022B, a 75.94% decline from 2022.
  • Sysmex ADR annual change in accounts receivable for 2022 was $-0.092B, a 12.2% increase from 2021.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$184.9B
Intuitive Surgical (ISRG)$169.9B
IDEXX Laboratories (IDXX)$51.8B
Edwards Lifesciences (EW)$47.7B
Alcon (ALC)$39.2B
IQVIA Holdings (IQV)$32.1B
DexCom (DXCM)$29.4B
Mettler-Toledo (MTD)$26.4B
STERIS (STE)$24.1B
Waters (WAT)$17.7B
SONOVA HOLDING (SONVY)$17.2B
Hologic (HOLX)$14.8B
Penumbra (PEN)$10.6B
Globus Medical (GMED)$8.3B
Masimo (MASI)$7.7B
Teleflex (TFX)$5.6B
Glaukos (GKOS)$5.5B
TransMedics (TMDX)$4B
Integer Holdings (ITGR)$3.8B
LivaNova (LIVN)$3B
Alphatec Holdings (ATEC)$2.4B
Veracyte (VCYT)$2.4B
PROCEPT BioRobotics (PRCT)$2.2B
Artivion (AORT)$2.1B
Nihon Kohden (NHNKY)$1.9B
Elekta AB (EKTAY)$1.8B
Integra LifeSciences Holdings (IART)$1.2B
OPKO Health (OPK)$1.1B
Paragon 28 (FNA)$1.1B
Pulse Biosciences (PLSE)$1B